Sutro Biopharma, Inc. (STRO) Social Stream
SUTRO BIOPHARMA INC (STRO) Price Targets From Analysts
Use the tables below to see what analysts covering SUTRO BIOPHARMA INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 6 | $37 | $29 | $34.2 | $5.06 | 575.89% |
| 2021-12-05 | 7 | $37 | $29 | $33.5 | $5.06 | 562.06% |
| 2022-05-09 | 7 | $37 | $29 | $32.333 | $5.06 | 538.99% |
| 2022-05-10 | 7 | $37 | $20 | $30.666 | $5.06 | 506.05% |
| 2022-05-11 | 7 | $37 | $20 | $29.833 | $5.06 | 489.58% |
| 2022-05-23 | 7 | $37 | $14 | $26.285 | $5.06 | 419.47% |
| 2022-08-10 | 7 | $37 | $16 | $26.571 | $5.06 | 425.12% |
| 2022-08-18 | 8 | $37 | $15 | $25.125 | $5.06 | 396.54% |
| 2022-11-09 | 8 | $33 | $15 | $21.875 | $5.06 | 332.31% |
| 2023-01-10 | 7 | $33 | $15 | $21 | $5.06 | 315.02% |
| 2023-01-13 | 7 | $33 | $15 | $21.571 | $5.06 | 326.3% |
| 2023-03-31 | 7 | $33 | $8 | $20.571 | $5.06 | 306.54% |
| 2023-05-16 | 8 | $25 | $8 | $18.428 | $5.06 | 264.19% |
| 2023-05-23 | 8 | $25 | $8 | $17.714 | $5.06 | 250.08% |
The Trend in the Analyst Price Target
STRO's average price target has moved down $16.49 over the prior 19 months.
STRO reports an average of 251.07% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-20 | 7 | 37 | 16 | 26.571 | 6.14 | 332.75% |
| 2022-08-18 | 8 | 37 | 15 | 25.125 | 6.64 | 278.39% |
| 2022-11-09 | 8 | 33 | 15 | 23.125 | 7.34 | 215.05% |
| 2022-11-09 | 6 | 33 | 15 | 21.875 | 7.34 | 198.02% |
| 2023-01-13 | 7 | 33 | 15 | 21.571 | 7.87 | 174.09% |
STRO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 7 | 0 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 17 months, STRO's average broker recommendation rating worsened by 0.25.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for STRO as an investment opportunity.
- STRO has a higher upside potential (average analyst target price relative to current price) than 1814% of all US stocks.
- In the context of all US stocks, SUTRO BIOPHARMA INC's variance in analysts' estimates is lower than -1347.37% of them.
- SUTRO BIOPHARMA INC's number of analysts covering the stock is higher than 1709.07% of stocks in the small market cap category.
- In the context of stocks in the small market cap category, SUTRO BIOPHARMA INC's average analyst price target is greater than 1254.79% of them.
Stocks similar to SUTRO BIOPHARMA INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AUTL, AVRO, and MGTX.
View All Top Stocks by Price Target
What is the outlook for STRO? Use POWR Ratings for clearer insight into price direction.